BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Enzelkitug readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Enzelkitug\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05581004-2471@assetmemo.bio
DTSTAMP:20261121T004502Z
DTSTART;VALUE=DATE:20280731
DTEND;VALUE=DATE:20280801
SUMMARY:Enzelkitug: Phase 1 readout est. (NCT05581004)
DESCRIPTION:Enzelkitug\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A St
 udy to Evaluate the Safety\, Pharmacokinetics\, and Activity of Enzelkitug
  as a Single Agent and in Combination With Checkpoint Inhibitor in Partici
 pants With Locally Advanced or Metastatic Solid Tumors\nEstimated primary 
 completion: 31 July 2028. This is a ClinicalTrials.gov estimate\, not a co
 nfirmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/
 drug/enzelkitug#upcoming-events\nRegistry record: https://clinicaltrials.g
 ov/study/NCT05581004
URL:https://assetmemo.bio/drug/enzelkitug#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
